Clustering data with hclust algorithm for Mitochondrial Lipid Profiles in Traumatic Optic Neuropathy (Study ST001327)
Reversed phase POSITIVE ION MODE (Analysis AN002210)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 |
|---|---|---|---|---|---|---|---|---|---|
| LPC(18:1) | ME309425 | 0.86 | 1.14 | 0.35 | 0.23 | 3.51 | 0.56 | 0.74 | 0.61 |
| LPC(18:2) | ME309426 | 0.15 | 0.65 | 0.44 | 0.45 | 4.85 | 0.91 | 0.30 | 0.25 |
| LPC(18:0) | ME309424 | 0.21 | 0.78 | 0.21 | 0.05 | 6.17 | 0.13 | 0.22 | 0.22 |
| LPC(20:4) | ME309427 | 0.00 | 0.59 | 0.00 | 0.00 | 5.61 | 0.00 | 0.00 | 0.00 |
| PE(18:0/18:1) | ME309435 | 0.82 | 1.81 | 1.10 | 0.02 | 0.83 | 0.73 | 1.62 | 1.08 |
| LPC(16:0) | ME309423 | 1.11 | 1.18 | 0.81 | 0.91 | 1.11 | 1.18 | 0.96 | 0.74 |
| CerG1(d18:0+pO/22:1) | ME309415 | 0.56 | 1.35 | 1.04 | 2.09 | 0.62 | 0.46 | 0.99 | 0.90 |
| CerG1(d18:1/24:1) | ME309419 | 0.57 | 1.46 | 0.95 | 1.71 | 0.69 | 0.56 | 0.99 | 1.06 |
| CerG1(d18:0+pO/24:1) | ME309416 | 0.60 | 1.82 | 0.89 | 1.11 | 0.73 | 0.58 | 1.15 | 1.12 |
| PC(36:1) | ME309434 | 0.66 | 1.74 | 1.03 | 1.27 | 1.08 | 0.67 | 0.94 | 0.61 |
| CerG1(d18:1/22:1) | ME309418 | 0.60 | 2.09 | 1.04 | 1.23 | 1.07 | 0.68 | 0.63 | 0.65 |
| PC(34:1) | ME309433 | 0.64 | 2.12 | 0.97 | 1.24 | 1.02 | 0.64 | 0.70 | 0.67 |
| PC(32:0) | ME309432 | 0.72 | 2.68 | 1.35 | 0.02 | 2.07 | 0.93 | 0.04 | 0.20 |
| CerG1(d42:1+pO) | ME309422 | 0.67 | 2.89 | 0.63 | NA | 1.51 | 0.78 | 0.07 | 0.23 |
| CerG1(d18:1/22:0+O) | ME309417 | 0.64 | 2.59 | 0.94 | NA | 1.69 | 0.86 | 0.04 | 0.24 |
| CerG1(d40:0+pO+O) | ME309421 | 0.64 | 2.59 | 0.94 | NA | 1.69 | 0.86 | 0.04 | 0.24 |
| PE(18:0p/18:1) | ME309436 | 0.67 | 3.45 | 1.27 | 0.09 | 1.25 | 0.68 | 0.28 | 0.33 |
| PE(18:1p/18:1) | ME309438 | 0.41 | 3.54 | 0.95 | 0.01 | 0.84 | 0.56 | 0.04 | 0.23 |
| PE(18:0p/20:1) | ME309437 | 0.46 | 3.36 | 1.16 | 0.06 | 0.98 | 0.45 | 1.09 | 0.44 |
| TG(18:1/18:1/18:2) | ME309448 | 0.72 | 3.46 | 0.53 | 0.31 | 1.09 | 0.89 | 0.66 | 0.34 |
| CerG1(d18:1/24:2) | ME309420 | 0.61 | 3.29 | 0.76 | 0.15 | 1.71 | 0.80 | 0.51 | 0.16 |
| SM(d42:2) | ME309442 | 0.45 | 2.99 | 1.02 | 0.42 | 1.32 | 0.61 | 0.79 | 0.26 |
| TG(16:0/16:0/18:1) | ME309443 | 0.48 | 5.31 | 0.24 | 0.26 | 0.31 | 0.52 | 0.34 | 0.19 |
| TG(18:1/18:1/18:1) | ME309447 | 0.64 | 5.01 | 0.20 | 0.40 | 0.60 | 0.57 | 0.39 | 0.19 |
| BisMePA(18:2p/20:1) | ME309414 | 0.56 | 4.44 | 0.70 | 0.04 | 1.31 | 0.71 | 0.13 | 0.12 |
| PS(18:0/20:1) | ME309441 | 0.39 | 4.71 | 0.39 | 0.41 | 0.74 | 0.57 | 0.49 | 0.30 |
| TG(16:0/18:1/18:1) | ME309444 | 0.64 | 4.30 | 0.39 | 0.44 | 0.76 | 0.66 | 0.52 | 0.30 |
| TG(16:0/18:1/18:2) | ME309445 | 0.50 | 4.29 | 0.39 | 0.11 | 1.00 | 0.73 | 0.57 | 0.40 |
| PS(18:0/18:1) | ME309440 | 0.60 | 3.73 | 0.57 | 0.84 | 0.62 | 0.45 | 0.66 | 0.54 |
| TG(18:0/16:0/18:1) | ME309446 | 1.11 | 3.90 | 0.46 | 0.47 | 0.49 | 0.85 | 0.30 | 0.42 |
| TG(18:1/18:2/18:2) | ME309449 | 1.48 | 3.91 | 0.02 | 0.08 | 0.77 | 0.82 | 0.21 | 0.22 |
Factors:
| F1 | Exposure:No Exposure | Days Post Exposure:Control | Sex:F |
| F2 | Exposure:No Exposure | Days Post Exposure:Control | Sex:M |
| F3 | Exposure:Sonication | Days Post Exposure:Day Fourteen | Sex:F |
| F4 | Exposure:Sonication | Days Post Exposure:Day Fourteen | Sex:M |
| F5 | Exposure:Sonication | Days Post Exposure:Day One | Sex:F |
| F6 | Exposure:Sonication | Days Post Exposure:Day One | Sex:M |
| F7 | Exposure:Sonication | Days Post Exposure:Day Seven | Sex:F |
| F8 | Exposure:Sonication | Days Post Exposure:Day Seven | Sex:M |
